MAL2 and colorectal cancer: Similar effects were observed for exogenous MAL2 in prostate [152], pancreatic [99], lung [149], and liver [108] cancer cells; for exogenous MALL in colorectal cancer cells [113]; and for CMTM8 in liver [153], pancreatic [119], and urothelial [116] cancer cells.